PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 154 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 1.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $30,555,000 | -64.4% | 4,500 | -50.5% | 0.01% | -62.5% |
| Q1 2017 | $85,904,000 | +578.5% | 9,100 | +203.3% | 0.02% | +700.0% |
| Q2 2016 | $12,660,000 | -3.2% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $13,080,000 | -76.3% | 3,000 | -66.7% | 0.00% | -77.8% |
| Q4 2015 | $55,170,000 | -79.5% | 9,000 | -83.2% | 0.01% | -79.5% |
| Q3 2013 | $269,105,000 | – | 53,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|